Exosomal miR-665 as a Novel Minimally Invasive Biomarker for Hepatocellular Carcinoma Diagnosis and Prognosis

Oncotarget - United States
doi 10.18632/oncotarget.20881
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

Exosomal microRNA‑210 Is a Potentially Non‑invasive Biomarker for the Diagnosis and Prognosis of Glioma

Oncology Letters
Cancer ResearchOncology
2020English

A Novel microRNAs Expression Signature for Hepatocellular Carcinoma Diagnosis and Prognosis

Oncotarget
Oncology
2017English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Serum Long Noncoding RNA LRB1 as a Potential Biomarker for Predicting the Diagnosis and Prognosis of Human Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1

Cellular Physiology and Biochemistry
Physiology
2019English

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

MiR-205 as a Promising Biomarker in the Diagnosis and Prognosis of Lung Cancer

Oncotarget
Oncology
2017English

Plasma Osteopontin as a Novel Diagnostic Biomarker for Early Detection of Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy